Pharmacokinetic Evaluation of EXPAREL in Adults Undergoing Tonsillectomy
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the pharmacokinetic (PK) profile of a single
dose of EXPAREL (133 mg/10 mL) administered intraoperatively per normal infiltration for
prolonged analgesia in 12 adult subjects undergoing tonsillectomy with or without removal of
the adenoids.